Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.47 USD
−154.99 M USD
0.00 USD
29.64 M
About Alumis Inc.
Sector
CEO
Martin Babler
Headquarters
San Francisco
Website
Founded
2021
FIGI
BBG01J7X4PN2
Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALMS is 8.04 USD — it has decreased by −5.10% in the past 24 hours. Watch Alumis Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alumis Inc. stocks are traded under the ticker ALMS.
ALMS stock has risen by 1.45% compared to the previous week, the month change is a −11.71% fall, over the last year Alumis Inc. has showed a −40.44% decrease.
We've gathered analysts' opinions on Alumis Inc. future price: according to them, ALMS price has a max estimate of 38.00 USD and a min estimate of 25.00 USD. Watch ALMS chart and read a more detailed Alumis Inc. stock forecast: see what analysts think of Alumis Inc. and suggest that you do with its stocks.
ALMS reached its all-time high on Jun 28, 2024 with the price of 13.53 USD, and its all-time low was 7.66 USD and was reached on Dec 5, 2024. View more price dynamics on ALMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALMS stock is 5.82% volatile and has beta coefficient of 0.91. Track Alumis Inc. stock price on the chart and check out the list of the most volatile stocks — is Alumis Inc. there?
Today Alumis Inc. has the market capitalization of 455.39 M, it has decreased by −4.23% over the last week.
Yes, you can track Alumis Inc. financials in yearly and quarterly reports right on TradingView.
Alumis Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ALMS earnings for the last quarter are −1.73 USD per share, whereas the estimation was −1.78 USD resulting in a 2.72% surprise. The estimated earnings for the next quarter are −1.31 USD per share. See more details about Alumis Inc. earnings.
Alumis Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ALMS net income for the last quarter is −93.12 M USD, while the quarter before that showed −56.51 M USD of net income which accounts for −64.79% change. Track more Alumis Inc. financial stats to get the full picture.
No, ALMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alumis Inc. stock right from TradingView charts — choose your broker and connect to your account.